Under the name of Frontotemporal Dementias (FTD) numerous hereditary and sporadic disorders are listed. FTD may take away speech and language, social skills and ethical judgement, wishes and will, empathy and emotions; it may also impair motor functions. FTD may affect men and women in midlife or during old age leading to the demolition of the uniqueness of the human mind.

In the last decade of the 20^th century and in the first two decades of the 21^st century, progress in the understanding of clinical, neuropathological, biochemical, and genetic aspects of FTD has accelerated. The novel awareness about FTD has directed young generations of researchers toward the study of this complex group of disorders.

This Volume has been formulated with the participation of some of the leading scientists who have contributed to the development of knowledge in the clinical and basic science arenas. It captures the current central elements thatare relevant to an up-to-date understanding of causes and pathogenesis of multiple forms of FTD.

The volume is an opus that represents a distillation of the work of many scientists and addresses the current directions in the study of one of the most complex groups of diseases. In view of its structure, the book could also be used as a textbook, that offers both a broad and deep analysis of major areas in FTD. 

This book, planned by the International Society for Frontotemporal Dementias, is distinctive as it opens a window to a wide landscape about the biology of FTD.

Thus, the book represents a moment of reflection on the present state of our knowledge of FTD and a collective vision toward scientific progress. The authors of each chapter share their knowledge  and vision aimed at reducing the suffering which is caused by FTD.

 

<p>1. Behavioural variant FTD: recent advances in the diagnosis and understanding of the disorder

2. The neuropsychiatry of frontotemporal dementia
3. Nosology and Neuropathology of Language in Primary Progressive Aphasia
4. Measuring Behavior and Cognition in FTLD
5.  Clinical update on C9orf72: FTD, ALS and beyond
6. Clinical aspects of familial FTLD associated with <i>MAPT</i> and <i>GRN</i> mutations
7. Neuroimaging in Frontotemporal Lobar Degeneration
8. The FTD Prevention Initiative - linking together genetic FTD cohort studies
9. Fluid Biomarkers of Frontotemporal Lobar Degeneration
10. Cross-cultural perspectives on frontotemporal degeneration
11. Clinical characteristics and Neuropathology of PSP, CBD and Related 4R-Tauopathies
12. Tau protein and frontotemporal dementias
13. FTLD-TDP pathological subtypes: clinical and mechanistic significance
14.  Lysosomal dysfunction as a pathogenic mechanism in FTD: Evidence from PGRN and TMEM106B genetics and biology
15. Future trends in understanding the pathological role of TDP-43 and FUS proteins
16. Description of a new data resource for FTD including multiomic data on human post mortem brain (MAPT, GRN, C9orf72), matching mouse models and iPS models
17. Mendelian and sporadic FTD: avenues from genetics to disease pathways through in-silico prediction and modeling
18. FTLD treatment:  Current Practice and Future Possibilities.</p><p></p>